ACVR2A and metabolic syndrome: In this study, we demonstrate that the administration of a combination of R+Q was able to prevent SO by decreasing the expression of MYOST and its receptors (ActRIIA and ActRIIB) and by increasing the expression of Smad 7 in MetS rats.